Bottom production in Photon and Pomeron -- induced interactions at the LHC

In this paper we present a detailed comparison of the bottom production in gluon -- gluon, photon -- gluon, photon -- photon, pomeron -- gluon, pomeron -- pomeron and pomeron -- photon interactions at the LHC. The transverse momentum, pseudo -- rapidity and $\xi$ dependencies of the cross sections are calculated at LHC energy using the Forward Physics Monte Carlo (FPMC), which allows to obtain realistic predictions for the bottom production with one or two leading intact protons. Moreover, predictions for the the kinematical range probed by the LHCb Collaboration are also presented. Our results indicate that the analysis of the single diffractive events is feasible using the Run I LHCb data.Comment: 8 pages, 3 figures, 1 table. Version published in Physical Review

Pheophorbide a identified in an Eupatorium perfoliatum extract is a novel lymphatic vascular activator

The lymphatic vascular system is crucial for maintaining tissue fluid homeostasis and immune surveillance. Promoting lymphatic function represents a new strategy to treat several diseases including lymphedema, chronic inflammation and impaired wound healing. By screening a plant extract library, a petroleum ether extract from the aerial parts of Eupatorium perfoliatum (E. perfoliatum) was found to possess lymphangiogenic properties. With the aid of HPLC activity profiling the active compound was identified as pheophorbide a. Both plant extract and pheophorbide a induced the sprouting and tube formation of human primary lymphatic endothelial cells (LECs). The proliferation of the LECs was increased upon treatment with pheophorbide a but not the E. perfoliatum extract. Treatment with the MEK1/2 inhibitor U0126 reduced the LEC sprouting activity, indicating a potential mechanism of action. These studies suggest that pheophorbide a could represent novel natural therapeutic agent to treat human lymphatic vascular insufficiencies

Identification of plant-derived alkaloids with therapeutic potential for myotonic dystrophy type I

Myotonic dystrophy type I (DM1) is a disabling neuromuscular disease with no causal treatment available. This disease is caused by expanded CTG trinucleotide repeats in the 3 UTR of the dystrophia myotonica protein kinase gene. On the RNA level, expanded (CUG)n repeats form hairpin structures that sequester splicing factors such as muscleblind-like 1 (MBNL1). Lack of availableMBNL1leads to misregulated alternative splicing of many target pre-mRNAs, leading to the multisystemic symptoms in DM1. Many studies aiming to identify small molecules that target the (CUG)n-MBNL1 complex focused on synthetic molecules. In an effort to identify new small molecules that liberate sequesteredMBNL1from (CUG)n RNA, we focused specifically on small molecules of natural origin. Natural products remain an important source for drugs and play a significant role in providing novel leads and pharmacophores for medicinal chemistry. In a new DM1 mechanism-based biochemical assay, we screened a collection of isolated natural compounds and a library of over 2100 extracts from plants and fungal strains. HPLC-based activity profiling in combination with spectroscopic methods were used to identify the active principles in the extracts. The bioactivity of the identified compounds was investigated in a human cell model and in a mouse model of DM1.We identified several alkaloids, including the -carboline harmine and the isoquinoline berberine, that ameliorated certain aspects of theDM1pathology in these models. Alkaloids as a compound class may have potential for drug discovery in other RNA-mediated diseases

Reporting guidelines for medicinal plant extracts used in pharmacological and toxicological research: ConPhyMP

Every year, the number of studies that evaluate the pharmacological effects, (clinical) efficacy or the toxicity of medicinal plant extracts is constantly increasing, but the reporting quality remains unsatisfactory. One of the main reasons is that there is a lack of detailed reporting standards for guidance. In response to this long-standing challenge, a core group of nine experts with proficiency in phytochemical analysis, including editors-in-chief of leading specialist journals, and based in different research settings globally, developed the Consensus based reporting guidelines for Phytochemical Characterisation of Medicinal Plant extracts (ConPhyMP) through a multi-staged development process. This incorporated a) a global survey among medicinal plant researchers, b) a core group, who reviewed and developed the guidelines through a Delphi process, and c) an advisory group of 20 experts, including editors of leading journals and scientific societies in medicinal plants research, who provided feedback and sanctioned the final guidelines. The ConPhyMP guidelines comprise two tables with accompanying explanatory figures. The first table provides recommendations for reporting the starting material and its initial processing, and the second table presents recommendations for conducting and reporting the analytical methods for defining the chemical profile based on the type of extracts used in the research. The group hopes that the ConPhyMP will support authors as well as peer reviewers and editors assessing these studies for publication and assist the production of evidence-based guidance of studies utilising medicinal plant extracts

Maximal planar networks with large clustering coefficient and power-law degree distribution

In this article, we propose a simple rule that generates scale-free networks with very large clustering coefficient and very small average distance. These networks are called {\bf Random Apollonian Networks}(RAN) as they can be considered as a variation of Apollonian networks. We obtain the analytic results of power-law exponent $\gamma =3$ and clustering coefficient $C={46/3}-36\texttt{ln}{3/2}\approx 0.74$, which agree very well with the simulation results. We prove that the increasing tendency of average distance of RAN is a little slower than the logarithm of the number of nodes in RAN. Since most real-life networks are both scale-free and small-world networks, RAN may perform well in mimicking the reality. The RAN possess hierarchical structure as $C(k)\sim k^{-1}$ that in accord with the observations of many real-life networks. In addition, we prove that RAN are maximal planar networks, which are of particular practicability for layout of printed circuits and so on. The percolation and epidemic spreading process are also studies and the comparison between RAN and Barab\'{a}si-Albert(BA) as well as Newman-Watts(NW) networks are shown. We find that, when the network order $N$(the total number of nodes) is relatively small(as $N\sim 10^4$), the performance of RAN under intentional attack is not sensitive to $N$, while that of BA networks is much affected by $N$. And the diseases spread slower in RAN than BA networks during the outbreaks, indicating that the large clustering coefficient may slower the spreading velocity especially in the outbreaks.Comment: 13 pages, 10 figure

Generic and Layered Framework Components for the Control of a Large Scale Data Acquisition System

The complexity of today's experiments in High Energy Physics results in a large amount of readout channels which can count up to a million and above. The experiments in general consist of various subsystems which themselves comprise a large amount of detectors requiring sophisticated DAQ and readout electronics. We report here on the structured software layers to control such a data acquisition system for the case of LHCb which is one of the four experiments for LHC. Additional focus is given on the protocols in use as well as the required hardware. An abstraction layer was implemented to allow access on the different and distinct hardware types in a coherent and generic manner. The hierarchical structure which allows propagating commands down to the subsystems is explained. Via finite state machines an expert system with auto-recovery abilities can be modeled

Administration of Silver Fir (Abies alba Mill.) to goats and its potential to control gastro-intestinal parasites

Gastrointestinal nematodes (GIN) substantially impact on goat health. Because of the widespread development of GIN, resistant to allopathic drugs, further research into alternative parasite control methods is required [1]. Silver fir, Abies alba MILL (SF), is traditionally used by Swiss farmers in order to control GIN infections of goats but also to improve animal welfare. A survey among goat farmers revealed that goat farmers use SF in winter during a period of approximately five months. The SF-ration per animal and day differ between approximately 8.2 g dry matter (DM) to 600 g DM [2]. As there is scientific evidence neither for an anthelmintic potential nor for the feed intake and milk performance of SF, we conducted a study with 30 goats. For a 20 days feeding experiment one group of 15 goats (A) was, additionally to their basic ration, daily fed with SF. The remaining 15 goats (group B) were fed with the basic ration only. Individual faecal egg counts (FEC) were conducted of all goats. Furthermore the effects of SF on the intake of the basic ration, milk yield and ingredients were tested. Total phenols (TP) and essential oils (EO) of 12 representative samples of the administered SF were determined by steam distillation and GS-MS-Analytic, respectively. SF contained 1,8 % TP. Limonene, bornyl acetate and beta caryophyllene were identified as the main EO. SF-feeding did not result in a reduction of GIN FEC (Fig 1). The intake of SF per animal and day was 261 +/- 0.22 g DM. Although SF reduced the basic forage intake significantly, SF increased the total DM intake significantly (A: 1948 +/- 93 g DM; B: 1797 +/- 93 g DM). SF feeding showed no effect on milk yield and milk components (Tab 1) [2]. Although farmers are convinced of the anthelmintic potential of SF, our short term study could not point to such an effect. It is possible that a prolonged period of SF administration is necessary in order for such effects to become apparent. [1] Jackson, N. F. und Coop, R. L. (2000). The development of anthelmintic resistance in sheep nematodes. Parasitology, 120(07):95 [2] Giebler-Schubert, Frauke (2013). Einsatz von Weißtanne zur Reduktion des Magen-Darm-Strongyliden-Befalls bei Ziegen: In-vivo-Versuche und Erfahrungswissen, Universität Hohenhei

Communicability in complex networks

Many topological and dynamical properties of complex networks are defined by assuming that most of the transport on the network flows along the shortest paths. However, there are different scenarios in which non-shortest paths are used to reach the network destination. Thus the consideration of the shortest paths only does not account for the global communicability of a complex network. Here we propose a new measure of the communicability of a complex network, which is a broad generalization of the concept of the shortest path. According to the new measure, most of real-world networks display the largest communicability between the most connected (popular) nodes of the network (assortative communicability). There are also several networks with the disassortative communicability, where the most "popular" nodes communicate very poorly to each other. Using this information we classify a diverse set of real-world complex systems into a small number of universality classes based on their structure-dynamic correlation. In addition, the new communicability measure is able to distinguish finer structures of networks, such as communities into which a network is divided. A community is unambiguously defined here as a set of nodes displaying larger communicability among them than to the rest of nodes in the network.Comment: 20 pages, 5 figure

Observation of two new Ξb−\Xi_b^- baryon resonances

Two structures are observed close to the kinematic threshold in the $\Xi_b^0 \pi^-$ mass spectrum in a sample of proton-proton collision data, corresponding to an integrated luminosity of 3.0 fb$^{-1}$ recorded by the LHCb experiment. In the quark model, two baryonic resonances with quark content $bds$ are expected in this mass region: the spin-parity $J^P = \frac{1}{2}^+$ and $J^P=\frac{3}{2}^+$ states, denoted $\Xi_b^{\prime -}$ and $\Xi_b^{*-}$. Interpreting the structures as these resonances, we measure the mass differences and the width of the heavier state to be $m(\Xi_b^{\prime -}) - m(\Xi_b^0) - m(\pi^{-}) = 3.653 \pm 0.018 \pm 0.006$ MeV$/c^2$, $m(\Xi_b^{*-}) - m(\Xi_b^0) - m(\pi^{-}) = 23.96 \pm 0.12 \pm 0.06$ MeV$/c^2$, $\Gamma(\Xi_b^{*-}) = 1.65 \pm 0.31 \pm 0.10$ MeV, where the first and second uncertainties are statistical and systematic, respectively. The width of the lighter state is consistent with zero, and we place an upper limit of $\Gamma(\Xi_b^{\prime -}) < 0.08$ MeV at 95% confidence level. Relative production rates of these states are also reported.Comment: 17 pages, 2 figure